Pharmacologic Management of Difficult-to-Treat Depression in Clinical Practice
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This article reviews the concept of difficult-to-treat depression and outlines some principles of pharmacologic management. METHODS: The authors conducted a MEDLINE review for the years 1999 to 2004, using the key words refractory, resistant, and difficult-to-treat depression. RESULTS: Only a small body of evidence-based literature exists to guide the management of difficult-to-treat depression. Nevertheless, clinicians often need to make treatment decisions in the absence of clear data. Depression should not be considered resistant, refractory, or difficult to treat in the absence of trials in which an appropriate drug is given in a dosage and duration sufficient to produce a response. Nevertheless, inadequate antidepressant trials are a relatively common phenomenon. Nonresponse may also result from pharmacokinetic or pharmacogenomic factors. Principals for assessing difficult-to-treat depression include preventing pseudo-resistant cases, recognizing that finding the best treatment option is a process, developing a systematic step-by-step approach, and preserving hope. A review of the literature demonstrated a two-step approach for managing difficult-to-treat depression. The first step is to evaluate for factors that contribute to nonresponse, such as comorbid medical and psychiatric conditions. The second step involves using the four classical strategies for enhancing antidepressant efficacy: optimization, augmentation, combination, and switching. CONCLUSION: Advances have been made in the treatment of depression, but a great deal more research needs to be done. It is hoped that new alternatives and promising developments in methods will contribute to the improved management of what we now call difficult-to-treat depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2003) · The Lancet · doi:10.1016/s0140-6736(03)12705-5 · Cited by 1,706
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression
Ostroff, R. B., & Nelson, J. C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0410 · Cited by 248
A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine
Carpenter, L. L., Yasmin, S., & Price, L. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01262-8 · Cited by 244
Venlafaxine for Treatment-Resistant Unipolar Depression
NIERENBERG, A. A., FEIGHNER, J. P., RUDOLPH, R., COLE, J. O., & SULLIVAN, J. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00008 · Cited by 198
Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison
Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.12 · Cited by 185
Can We Predict the Persistence of Depression?
Scott, J., Eccleston, D., & Boys, R. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.5.633 · Cited by 131
Cited by
Berlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412
“In such cases, dosage adjustments may produce a significant treatment improvement.(27)”
BackgroundMcIntyre, A., Gendron, A., & McIntyre, A. (2007) · Depression and Anxiety · doi:10.1002/da.20275 · Cited by 145
Carvalho, A. F., Cavalcante, J. L., Castelo, M. S., & Lima, M. C. O. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00846.x · Cited by 110
“A clinician dealing with a patient with TRD should always re-evaluate the primary diagnosis and rule out the possibility that untreated general medical and psychiatric co-morbidities might be responsible for the therapeutic failure (12).”
BackgroundKeitner, G. I., Garlow, S. J., Ryan, C. E., Ninan, P. T., Solomon, D. A., Nemeroff, C. B., & Keller, M. B. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.003 · Cited by 108
“Switching antidepressants, combining antidepressants, and augmenting the first-line antidepressant treatment with lithium or thyroid hormone therapy are frequently used treatment options for antidepressant non-responders (Fleck and Horwath, 2005; Keller, 2005; Thase, 2002).”
Background
Metadata
- Authors
- Fleck, M. P., & Horwath, E.
- Venue
- Psychiatric Services
- Published
- 2005-08
- Volume
- 56
- Issue
- 8
- Pages
- 1005-1011
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2137128030
- Cited by
- 38
- References
- 8
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.